Clinical Trials Sponsored by Abbott (Ukraine)

Total 2009 results

Abbott

Completed

A Study of Pain Relief in Low Back Pain

Chronic Low Back Pain

United States
Abbott

Completed

Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children

Premature Birth | Congenital Heart Disease | Bronchopulmonary Dysplasia | Respiratory Syncytial Virus Infection

Russian Federation
Abbott

Completed

Recovery Time in Thai Patients With Upper or Lower Respiratory Tract Infections Treated With Klacid MR

Respiratory Tract Infection

Thailand
Abbott

Completed

Evaluation of the Treatment With Klacid SR in Patients With Acute Tracheitis, Tracheobronchitis and Bronchitis, Acute Exacerbation of Chronic Bronchitis and Mild Community-acquired Pneumonia in Common Clinical Practice in Ukraine (KLARAINE)

Respiratory Tract Infections

Ukraine
Abbott

Completed

An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME) (SUPREME)

Hyperlipidemia | Mixed Dyslipidemia

United States
Abbott

Completed

Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patients With High Risk of Developing Diabetes Mellitus (TARDIA)

Hypertension

Bulgaria, Czech Republic, Romania, Russian Federation, Slovakia, Slovenia, Ukraine
Abbott

Completed

Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States, Denmark, Germany, Netherlands
Abbott

Completed

A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Russian Federation
Abbott

Completed

Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment (BELIEVE)

Chronic Plaque Psoriasis

Belgium, Denmark, France, Germany, Spain, Sweden, Switzerland, Finland, Turkey, Italy, Czech Republic, Austria, Netherlands, United Kingdom, Greece
Abbott

Completed

Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected Subjects

Human Immunodeficiency Virus Infections

United States
Abbott

Completed

Recovery Time in Children With Lower Respiratory Tract Infections Treated With Klacid® Granules for Oral Suspension.

Lower Respiratory Tract Infection

Thailand
Abbott

Completed

Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon

Crohn's Disease

United States, Germany, Belgium, Canada, Netherlands, Italy, Austria, France
Abbott

Completed

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-384 in Elderly Subjects

Healthy

United States
Abbott

Completed

A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ABT-436 in Healthy Adults

Healthy

United States
Abbott

Completed

Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of ABT-614 on [11C]-(+)-PHNO Binding Potential to D3 Receptors in the Brain

Healthy Volunteers

Canada
Abbott

Completed

A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, Metabolized and Eliminated in Humans

Healthy

United States
Abbott

Completed

Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia

Schizophrenia

United States
Abbott

Terminated

Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheumatoid Arthritis Treated With Humira (VIVIR)

Rheumatoid Arthritis

Puerto Rico
Abbott

Completed

Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood

Dyslipidemia | Coronary Heart Disease | Mixed Dyslipidemia

United States
Abbott

Completed

Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood

Dyslipidemia | Coronary Heart Disease | Mixed Dyslipidemia

United States
Abbott

Completed

Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood

Dyslipidemia | Coronary Heart Disease | Mixed Dyslipidemia

United States
Abbott

Completed

Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM) (TANDEM)

Hypertension | Diabetes | Proteinuria
Abbott

Completed

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients (KALEAD)

HIV Infection

United States
Abbott

Completed

A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids

Metrorrhagia | Leiomyoma | Menorrhagia
Abbott

Completed

A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Women With Endometriosis From Study M01-398

Endometriosis
Abbott

Completed

Treatment of Uterine Fibroids With Asoprisnil(J867)

Metrorrhagia | Leiomyoma | Menorrhagia
Abbott

Completed

A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)

Psoriatic Arthritis
Abbott

Completed

ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects

HIV Infections

United States
Abbott

Completed

Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis
Abbott

Completed

Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Psoriasis
Abbott

Completed

Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Psoriasis
Abbott

Completed

Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Psoriasis
Abbott

Completed

Pediatric Switch Study for Children and Adolescent Patients With Epilepsy

Pediatric Epilepsy

United States
Abbott

Completed

Comparative Study of the Safety and Efficacy of Clarithromycin Extended-Release Tablets Versus Amoxicillin-Clavulanate for the Treatment of Acute Bacterial Sinusitis

Acute Bacterial Sinusitis (ABS)

Italy, Spain, Greece, United States, Canada, Poland, Lithuania, Hungary, Romania
Abbott

Completed

Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis

Acute Bacterial Sinusitis

United States, Poland
Abbott

Completed

Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis Media

Acute Otitis Media

Costa Rica, United States, Guatemala, Israel, Chile, Dominican Republic, Panama
Abbott

Terminated

Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects

Obesity | Weight Loss
Abbott

Completed

A Study of ABT-751 in Patients With Colorectal Cancer

Colorectal Cancer

United States
Abbott

Completed

Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE)

Crohn's Disease

United States
Abbott

Completed

A Study of ABT-751 in Patients With Renal Cell Cancer

Renal Cell Cancer

Canada, United States
Abbott

Completed

A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin

Hyperlipidemia
Abbott

Completed

Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis (HERO)

Rheumatoid Arthritis

United States
Abbott

Completed

Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer

Prostatic Neoplasms

Canada, United States, Spain, Belgium, Australia, Italy, United Kingdom, Germany, France, Sweden, South Africa, Netherlands, Ireland, New Zealand, Greece, Poland, Austria
Abbott

Terminated

Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

United States
Abbott

Completed

A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents

Bipolar I Disorder

United States
Abbott

Terminated

Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Abbott

Completed

The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents

Migraine

United States
Abbott

Completed

A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer

Prostate Cancer

United States, Canada, France, Spain, Belgium, Australia, United Kingdom, Italy, Sweden, South Africa, Netherlands, Ireland, Germany, Austria, New Zealand, Greece, Poland, Switzerland
Abbott

Completed

Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Abbott

Completed

A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors

HIV Infections

United States, France, Spain

3

Subscribe